Anti-CD38 Pretargeted Radioimmunotherapy Eradicates Multiple Myeloma Xenografts In a Murine Model

被引：3
|
作者：
Green, Damian J.
Jones, Jon C.
Hylarides, Mark D.
Hamlin, Donald K.
Wilbur, D. Scott
Lin, Yukang
Kenoyer, Aimee L.
Frayo, Shani L.
Bensinger, William I.
Gopal, Ajay K.
Orozco, Johnnie J.
Gooley, Theodore A.
Wood, Brent L.
Pagel, John M.
Press, Oliver W.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.882.882
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
882
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Anti-CD38 Pretargeted Radioimmunotherapy Demonstrates Therapeutic Efficacy In a Human Multiple Myeloma Mouse Xenograft Model
    Green, Damian J.
    Orgun, Nural N.
    Hylarides, Mark D.
    Pagel, John M.
    Hamlin, Donald K.
    Wilbur, D. Scott
    Lin, Yukang
    Kenoyer, Amiee L.
    Frayo, Shani L.
    Bensinger, William I.
    Gopal, Ajay K.
    Orozco, Johnnie J.
    Gooley, Theodore A.
    Wood, Brent L.
    Press, Oliver W.
    BLOOD, 2011, 118 (21) : 802 - 803
  • [2] The Anti-CD38 Antibody Therapy in Multiple Myeloma
    Petrucci, Maria Teresa
    Vozella, Federico
    CELLS, 2019, 8 (12)
  • [3] Anti-CD38 nanobodies as theranostic agents for multiple myeloma
    Duray, Elodie
    Lejeune, Margaux
    Dumoulin, Mireille
    D'Huyvetter, Matthias
    Caers, Jo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S28 - S28
  • [4] Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma
    Saltarella, Ilaria
    Desantis, Vanessa
    Melaccio, Assunta
    Solimando, Antonio Giovanni
    Lamanuzzi, Aurelia
    Ria, Roberto
    Storlazzi, Clelia Tiziana
    Mariggio, Maria Addolorata
    Vacca, Angelo
    Frassanito, Maria Antonia
    CELLS, 2020, 9 (01)
  • [5] Anti-CD38 Targeted Nanoparticles for Drug Delivery in Multiple Myeloma
    De La Puente, Pilar
    Jin, Abbey
    Luderer, Micah John
    Muz, Barbara
    King, Justin A.
    Vij, Ravi
    Azab, Abdel Kareem
    BLOOD, 2016, 128 (22)
  • [6] DARATUMUMAB Anti-CD38 Monoclonal Antibody, Treatment of Multiple Myeloma
    Richardson, P.
    Lokhorst, H.
    Palumbo, A.
    Nahi, H.
    Laubach, J.
    Gimsing, P.
    Lisby, S.
    Cakana, A.
    Brun, N. Constantin
    Plesner, T.
    DRUGS OF THE FUTURE, 2013, 38 (08) : 545 - 554
  • [7] Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model
    Zannetti, Beatrice Anna
    Faini, Angelo Corso
    Massari, Evita
    Geuna, Massimo
    Maffini, Enrico
    Poletti, Giovanni
    Cerchione, Claudio
    Martinelli, Giovanni
    Malavasi, Fabio
    Lanza, Francesco
    CELLS, 2020, 9 (12) : 1 - 13
  • [8] Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen?
    D'Agostino, Mattia
    Mina, Roberto
    Gay, Francesca
    LANCET HAEMATOLOGY, 2020, 7 (05): : E355 - E357
  • [9] The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma
    Moreno, Laura
    Perez, Cristina
    Zabaleta, Aintzane
    Manrique, Irene
    Alignani, Diego
    Ajona, Daniel
    Blanco, Laura
    Lasa, Marta
    Maiso, Patricia
    Rodriguez, Idoia
    Garate, Sonia
    Jelinek, Tomas
    Segura, Victor
    Moreno, Cristina
    Merino, Juana
    Rodriguez-Otero, Paula
    Panizo, Carlos
    Prosper, Felipe
    San-Miguel, Jesus F.
    Paiva, Bruno
    CLINICAL CANCER RESEARCH, 2019, 25 (10) : 3176 - 3187
  • [10] Serological Investigation in a Multiple Myeloma Patient receiving Daratumumab (Anti-CD38)
    Oldfield, L.
    Ison, T.
    Lau, W.
    TRANSFUSION, 2016, 56 : 135A - 136A
12345